Development of a comparative high-throughput screening platform for identifying glioblastoma subtype specific inhibitors
{{output}}
Glioblastoma (GBM) is the most lethal primary malignant brain tumor in adults, with the development of effective therapeutic agents largely hampered by vast tumor heterogeneity and the impedance of efficient drug delivery by the blood-brain barrier (BBB). Our ... ...
